Drug intelligence / Profile preview

Fruitomin

Development stage
Unknown
Lead developer
Taj Pharmaceuticals
Modality
Small Molecules
Administration
Intravenous
01

Overview

Fruitomin is a parenteral nutrition therapy developed by Taj Pharma, formulated as an intravenous injection containing a balanced mixture of essential amino acids, vitamins, and fructose (fruit sugar). It is primarily indicated for patients requiring nutritional support due to an inability to ingest or absorb nutrients through the gastrointestinal tract, such as those recovering from major surgery, severe trauma, or chronic wasting diseases. The amino acids in the formulation provide the necessary building blocks for protein biosynthesis and the maintenance of a positive nitrogen balance. Fructose serves as an immediate carbohydrate energy source, while the included vitamins (typically B-complex and Vitamin C) act as vital cofactors for various metabolic and enzymatic pathways, supporting cellular repair and immune function.

Brand names
FruitominFruitomin-Taj Pharma
Other names
Amino Acids with Vitamins and Fructose Injection
02

Targets

KHK-C (Ketohexokinase C)

Beyond the preview

Go deeper on Fruitomin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fruitomin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call